Citigroup’s Mead Johnson Nutrition Company MJN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-4,800
Closed -$428K 7656
2017
Q1
$428K Buy
4,800
+4,300
+860% +$354K ﹤0.01% 4005
2016
Q4
$35K Sell
500
-6,100
-92% -$455K ﹤0.01% 6313
2016
Q3
$521K Buy
6,600
+6,100
+1,220% +$520K ﹤0.01% 3863
2016
Q2
$45K Sell
500
-1,400
-74% -$119K ﹤0.01% 5640
2016
Q1
$161K Buy
+1,900
New +$141K ﹤0.01% 5293
2015
Q1
Sell
-10,000
Closed -$1M 7624
2014
Q4
$1M Hold
10,000
﹤0.01% 3131
2014
Q3
$962K Hold
10,000
﹤0.01% 3043
2014
Q2
$932K Sell
10,000
-67,500
-87% -$5.9M ﹤0.01% 3019
2014
Q1
$6.44M Buy
77,500
+67,500
+675% +$5.47M 0.01% 1506
2013
Q4
$838K Hold
10,000
﹤0.01% 3353
2013
Q3
$743K Sell
10,000
-29,200
-74% -$2.19M ﹤0.01% 3118
2013
Q2
$3.11M Buy
+39,200
New +$3.14M ﹤0.01% 2043

Other funds holding MJN

Citigroup's MJN Position: Q2 2017 in Review

Citigroup sold out of Mead Johnson Nutrition Company (MJN) in Q2 2017, closing a stake of 1,117,834 shares — an estimated $99.6M sold.

Citigroup first reported a position in MJN in Q2 2013 and held it in 16 quarters. The position peaked at $99.6M in Q1 2017. 7 funds tracked by Wall St. Rank hold MJN as of Q2 2017.

  • Citigroup reported no remaining Mead Johnson Nutrition Company position as of Q2 2017 after selling out during the quarter.
  • Citigroup sold 1,117,834 Mead Johnson Nutrition Company shares in Q2 2017, an estimated $99.6M.
  • Citigroup first reported a position in Mead Johnson Nutrition Company in Q2 2013 and held it in 16 quarters.
  • Citigroup's Mead Johnson Nutrition Company position peaked at $99.6M in Q1 2017.
  • 7 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q2 2017.

Based on Citigroup's 13F filing for Q2 2017, filed 11 Aug 2017.